Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials
Authors
Keywords
-
Journal
MATURITAS
Volume -, Issue -, Pages 107874
Publisher
Elsevier BV
Online
2023-11-01
DOI
10.1016/j.maturitas.2023.107874
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice
- (2023) Evrydiki Kravvariti et al. OSTEOPOROSIS INTERNATIONAL
- Prevalence and patterns of anti-osteoporotic drug use based on 2019 real-world nationwide data in Greece
- (2022) Maria P. Yavropoulou et al. Archives of Osteoporosis
- The Efficacy and Safety of Abaloparatide‐SC in Men With Osteoporosis: A Randomized Clinical Trial
- (2022) Edward Czerwinski et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Abaloparatide Increases Lumbar Spine and Hip BMD in Japanese Patients With Osteoporosis: The Phase 3 ACTIVE-J Study
- (2022) Toshio Matsumoto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adherence to Anti-Osteoporotic Treatment and Clinical Implications after Hip Fracture: A Systematic Review
- (2021) Ramona Dobre et al. Journal of Personalized Medicine
- Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
- (2021) Athanasios D Anastasilakis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo and Nocebo Effects
- (2020) Luana Colloca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nocebo phenomena may be enhanced in aging: Implications for clinical practice
- (2020) E. Kravvariti et al. MATURITAS
- Public priorities for osteoporosis and fracture research: results from a focus group study
- (2020) Ashley Hawarden et al. Archives of Osteoporosis
- Diarrhoea in Systemic Sclerosis Patients as a Nocebo Effect of Nintedanib
- (2020) Vasiliki-Kalliopi Bournia et al. EUROPEAN RESPIRATORY JOURNAL
- The treatment gap: The missed opportunities for osteoporosis therapy
- (2020) Nicholas R. Fuggle et al. BONE
- Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2019) Christopher Ma et al. Journal of Crohns & Colitis
- Factors Associated With Age Disparities Among Cancer Clinical Trial Participants
- (2019) Ethan B. Ludmir et al. JAMA Oncology
- Inadequate description of placebo and sham controls in a systematic review of recent trials
- (2019) Rebecca K. Webster et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
- (2019) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink
- (2019) J. Morley et al. OSTEOPOROSIS INTERNATIONAL
- Adherence to Teriparatide Treatment and Risk of Fracture: A Systematic Review and Meta-Analysis
- (2019) Qing Chen et al. HORMONE AND METABOLIC RESEARCH
- FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab
- (2018) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
- (2018) E Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Psychobiological Mechanisms of Placebo and Nocebo Effects: Pathways to Improve Treatments and Reduce Side Effects
- (2018) Keith J. Petrie et al. Annual Review of Psychology
- Nocebos in rheumatology: emerging concepts and their implications for clinical practice
- (2018) Evrydiki Kravvariti et al. Nature Reviews Rheumatology
- International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates
- (2017) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
- (2017) A. Fahrleitner-Pammer et al. Archives of Osteoporosis
- A systematic review of sex differences in the placebo and the nocebo effect
- (2017) Sara Vambheim et al. Journal of Pain Research
- Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials
- (2016) Kun Zou et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Crisis in the Treatment of Osteoporosis
- (2016) Sundeep Khosla et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis
- (2016) X. Wu et al. OSTEOPOROSIS INTERNATIONAL
- Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996-2012: An Ecological Analysis
- (2015) Smita Jha et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials
- (2015) Panagiotis Zis et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study
- (2015) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
- (2014) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abandoned Acid? Understanding Adherence to Bisphosphonate Medications for the Prevention of Osteoporosis among Older Women: A Qualitative Longitudinal Study
- (2014) Charlotte Salter et al. PLoS One
- Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study
- (2013) Leslie Hazel-Fernandez et al. BMC MUSCULOSKELETAL DISORDERS
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Using Sherlock and ClinicalTrials.gov Data to Understand Nocebo Effects and Adverse Event Dropout Rates in the Placebo Arm
- (2013) M. Soledad Cepeda et al. JOURNAL OF PAIN
- Nocebo in clinical trials for depression: A meta-analysis
- (2013) Dimos D. Mitsikostas et al. PSYCHIATRY RESEARCH
- Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile
- (2013) J. D. Ringe et al. RHEUMATOLOGY INTERNATIONAL
- Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
- (2012) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
- (2012) Eric Orwoll et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lay understanding of common medical terminology in oncology
- (2012) Arwen H. Pieterse et al. PSYCHO-ONCOLOGY
- Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice
- (2011) D. D. Mitsikostas et al. EUROPEAN JOURNAL OF NEUROLOGY
- The impact of teriparatide adherence and persistence on fracture outcomes
- (2011) S. Yu et al. OSTEOPOROSIS INTERNATIONAL
- GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates
- (2011) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis
- (2011) T. Nakamura et al. OSTEOPOROSIS INTERNATIONAL
- Lessons learned from placebo groups in antidepressant trials
- (2011) M. S. Mora et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases
- (2010) Akimitsu Miyauchi et al. BONE
- Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer
- (2009) Maxine de la Cruz et al. CANCER
- Gender and the nocebo response following conditioning and expectancy
- (2009) Sibylle Klosterhalfen et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of adverse events in placebo groups of anti-migraine clinical trials
- (2009) Martina Amanzio et al. PAIN
- Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
- (2008) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments
- (2007) Fabrizio Benedetti Annual Review of Pharmacology and Toxicology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started